Clinical Trial Update: Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update involving hydroxychloroquine and azithromycin for SARS-CoV-2 pneumonia and COVID-19; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2 Pneumonia

Drugs mentioned

• Azithromycin (azithromycin)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Centre Hôpital Universitaire Farhat Hached | Conditions: SARS-CoV-2 Pneumonia, COVID-19 | Phase 3 | Status: UNKNOWN